Problems with US Health Agencies and New Medicines

A2

Problems with US Health Agencies and New Medicines

Introduction

The FDA has problems with its leaders. Also, few people use new medicines for Alzheimer's disease.

Main Body

People think the FDA leader, Marty Makary, might lose his job. This makes the agency unstable. Two new Alzheimer's drugs are Leqembi and Kisunla. The government thought these drugs would cost billions of dollars. Now, the government says the cost will be low because few patients use them. These drugs are hard to use. Patients need special machines and needles. Some drugs also cause brain bleeding. Also, some pharmacies say there are no estrogen patches, but the FDA does not agree.

Conclusion

The FDA has leadership problems. Also, expensive Alzheimer's drugs are not popular.

Learning

💡 The Word 'ALSO'

In the text, the writer uses the word also many times. This is a perfect tool for A2 students to connect ideas without using complex sentences.

How it works: Use it when you want to add one more piece of information to your list.

  • Example 1: The FDA has problems. Also, few people use the drugs.
  • Example 2: Drugs need needles. Also, they cause bleeding.

The Pattern \rightarrow [Fact A]. Also, [Fact B].


💊 Simple Vocabulary for Health

Look at these word pairs from the article to describe medical situations:

WordMeaning in simple English
AgencyA big government group
PatientA person who is sick
PharmacyA shop that sells medicine
UnstableNot steady / changing fast

Vocabulary Learning

problem (n.)
a situation that is difficult or unpleasant
Example:The problem with the door is that it doesn't close.
leader (n.)
a person who guides or directs others
Example:The leader of the class gave a short speech.
few (adj.)
a small number of
Example:She has few friends in the city.
people (n.)
human beings
Example:Many people went to the park.
use (v.)
to employ something
Example:I use a pen to write.
new (adj.)
recently made or discovered
Example:They bought a new car.
medicine (n.)
a substance used to treat illness
Example:He took medicine for his cough.
disease (n.)
a sickness that makes people ill
Example:Flu is a common disease.
cost (n.)
the amount of money needed
Example:The cost of the book is ten dollars.
patient (n.)
a person receiving medical care
Example:The patient was given a checkup.
machine (n.)
a device that helps do work
Example:The machine can print photos.
needle (n.)
a thin metal tip used for injections
Example:She used a needle to draw blood.
B2

Analysis of Regulatory Changes and Pharmaceutical Trends in U.S. Health Agencies

Introduction

Recent events show significant leadership instability at the Food and Drug Administration (FDA) and a large difference between the expected and actual use of new Alzheimer's treatments.

Main Body

Stability within the FDA is currently at risk due to rumors that Commissioner Marty Makary might be removed from his position. This uncertainty happens at the same time as a shift in the pharmaceutical market, specifically regarding the drugs Leqembi and Kisunla. Although the Centers for Medicare and Medicaid Services (CMS) previously predicted that Leqembi would cost billions of dollars per year, new projections for 2026 and 2027 suggest a very low financial impact because few patients are using the drug. Experts emphasize that this low adoption rate is caused by several clinical and systemic problems. For example, the need for intravenous administration and frequent medical imaging creates a heavy workload for healthcare providers. Furthermore, the number of eligible patients is limited, and some doctors question the benefits of these drugs because of the risk of serious side effects, such as brain bleeding. Additionally, there is a disagreement between pharmacy reports and federal records regarding estrogen patch shortages; while the American Society of Health-System Pharmacists has reported shortages since January, the FDA has not officially recognized them.

Conclusion

In summary, the U.S. healthcare sector is currently facing leadership problems at the FDA and a failure of expensive Alzheimer's medications to reach their expected usage levels.

Learning

⚡ The 'Professional Glue': Mastering Connector Words

At the A2 level, you usually use and, but, and because. To reach B2, you need Connectors. These are words that glue your ideas together to make you sound more academic and fluent.

Look at how this text moves from one idea to another without using basic words:

1. Adding Information (Beyond 'And')

  • Furthermore \rightarrow Used to add a new, important point.
  • Additionally \rightarrow Used to add extra information to a list.
  • B2 Tip: Start a sentence with these words followed by a comma (e.g., "Furthermore, the cost is high.") to instantly sound more professional.

2. Showing Contrast (Beyond 'But')

  • Although \rightarrow This introduces a surprising contrast.
  • While \rightarrow Used to compare two different situations happening at once.
  • A2 \rightarrow B2 Shift: Instead of saying "It is expensive but few people use it," try "Although it is expensive, few people use it."

3. Explaining Results (Beyond 'So')

  • Due to \rightarrow This connects a result to a specific cause (e.g., "Stability is at risk due to rumors").
  • B2 Tip: Due to is followed by a noun (a thing), not a full sentence. This is a key marker of advanced English.

Quick Reference Table for your Transition:

A2 Word (Basic)B2 Alternative (Professional)Purpose
AndFurthermore / AdditionallyAdding
ButAlthough / WhileContrasting
Because ofDue toExplaining

Vocabulary Learning

stability
The state of being steady and not changing.
Example:The company's stability was threatened by market fluctuations.
instability
Lack of steady state; tendency to change.
Example:Economic instability can lead to uncertainty among investors.
commissioner
A person appointed to a government position, especially in an agency.
Example:The commissioner announced new regulations for drug approval.
pharmaceutical
Relating to the preparation, use, or sale of drugs.
Example:The pharmaceutical industry is heavily regulated by the FDA.
predicted
Forecasted or expected to happen based on data.
Example:The analyst predicted a rise in drug prices next year.
projections
Estimates or forecasts of future events or numbers.
Example:Future projections show growth in the market for Alzheimer’s drugs.
adoption
The act of taking up or using something new.
Example:The adoption of the new treatment was slow among clinicians.
clinical
Relating to the treatment of patients in a medical context.
Example:Clinical trials are essential before a drug can be approved.
systemic
Affecting or relating to an entire system or organization.
Example:Systemic issues in the healthcare system need comprehensive solutions.
intravenous
Administered directly into a vein.
Example:The drug is given intravenously to ensure quick absorption.
administration
The act of giving or applying something, especially medicine.
Example:The administration of the vaccine must follow strict protocols.
frequent
Occurring often or many times.
Example:Frequent check-ups are required for patients on this medication.
medical imaging
Techniques like X-ray or MRI used to see inside the body.
Example:Medical imaging helps doctors diagnose fractures accurately.
workload
The amount of work required to be done.
Example:The workload increased after the new policy was implemented.
eligible
Qualified or allowed to receive something.
Example:Only eligible patients can receive the new drug.
disagreement
Lack of agreement or conflict over something.
Example:There was a disagreement among experts about the drug’s safety.
pharmacy
A place where medicines are sold or dispensed.
Example:The pharmacy stocked the new medication for patients.
federal
Relating to the national government.
Example:Federal regulations govern the approval of new drugs.
estrogen
A hormone produced mainly in the ovaries.
Example:Estrogen levels decline during menopause.
patch
A small piece of material applied to the skin to deliver medicine.
Example:The estrogen patch is applied daily to maintain hormone levels.
shortages
Lack or insufficient supply of something.
Example:Shortages of the drug were reported last month.
officially
Formally or in an official capacity.
Example:The agency officially announced the change in policy.
recognized
Acknowledged or accepted as true or real.
Example:The shortage was officially recognized by the FDA.
failure
Lack of success or inability to achieve a goal.
Example:The failure of the drug to meet expectations disappointed investors.
leadership
Ability to guide or direct others.
Example:Leadership at the agency was questioned after the controversy.
risk
Possibility of danger or loss.
Example:The risk of side effects is higher with older patients.
rumors
Unverified or informal information that spreads.
Example:Rumors about the drug’s safety circulated among doctors.
removed
Taken away from a position or place.
Example:He was removed from his post after the investigation.
position
A job or role held by someone.
Example:She held the position of director for five years.
shift
Change or movement from one state to another.
Example:A shift in policy occurred after new data emerged.
market
A place or system where goods are bought and sold.
Example:The pharmaceutical market is highly competitive.
cost
Amount of money needed to buy something.
Example:The cost of treatment can be a barrier for some patients.
billions
A number equivalent to a thousand million.
Example:The company invested billions in research and development.
financial
Relating to money or finances.
Example:The financial impact of the new regulations was minimal.
impact
Effect or influence of something.
Example:The impact of the decision was felt across the industry.
patients
People receiving medical care.
Example:Patients were monitored closely during the trial.
usage
Act of using something.
Example:The usage of the drug increased after the study.
side effects
Unwanted reactions caused by a medicine.
Example:Common side effects include nausea and dizziness.
brain bleeding
Bleeding inside the brain.
Example:Brain bleeding can occur as a serious complication.
reports
Documents or statements that give information.
Example:Reports were filed with the authorities after the incident.
records
Official documents that record events or data.
Example:Records show the drug’s supply levels over time.
January
The first month of the year.
Example:January is the month when the new regulations take effect.
C2

Analysis of Current Regulatory Instability and Pharmaceutical Adoption Trends within U.S. Health Agencies

Introduction

Recent developments indicate significant administrative volatility at the Food and Drug Administration (FDA) alongside a marked discrepancy between projected and actual utilization of novel Alzheimer's therapeutics.

Main Body

Institutional stability within the FDA is currently compromised by speculation regarding the potential removal of Commissioner Marty Makary from his position. This administrative uncertainty coincides with a broader shift in the pharmaceutical landscape, specifically regarding the adoption of Leqembi and Kisunla. While the Centers for Medicare and Medicaid Services (CMS) previously forecasted multi-billion dollar annual expenditures for Leqembi, current projections for 2026 and 2027 indicate a negligible fiscal impact due to muted patient uptake. This lack of market penetration is attributed to several systemic and clinical impediments. The requirement for intravenous administration and extensive diagnostic imaging imposes significant logistical burdens on healthcare providers. Furthermore, the eligible patient cohort remains restricted, and the clinical utility of these agents is questioned given the marginal benefits relative to the risk of severe adverse events, such as cerebral hemorrhaging. Parallel to these developments, a discrepancy exists between professional pharmacy reports and federal records regarding estrogen patch availability; while the American Society of Health-System Pharmacists has identified shortages since January, the FDA has not formally recognized these deficits.

Conclusion

The U.S. healthcare sector is currently characterized by leadership instability at the FDA and a failure of high-cost Alzheimer's medications to meet anticipated adoption rates.

Learning

The Architecture of 'Clinical Neutrality' and Nominalization

To transition from B2 to C2, a student must move beyond describing actions and begin describing states and phenomena. The provided text is a masterclass in Nominalization—the process of turning verbs (actions) into nouns (concepts). This is the primary tool for achieving the 'detached' academic tone required in high-level regulatory and scientific discourse.

🧩 The Shift: From Action to Concept

Compare a B2 approach to the C2 phrasing found in the text:

  • B2 (Action-oriented): "The FDA is unstable because people think Marty Makary might be removed." \rightarrow Focus on the people and the action.
  • C2 (Concept-oriented): "Institutional stability... is currently compromised by speculation regarding the potential removal..."

By using speculation and removal as nouns, the writer removes the 'actor' and focuses on the 'condition.' This creates an aura of objectivity and intellectual distance.

⚡ Precision through 'Low-Frequency' Collocations

C2 mastery is not about 'big words,' but about precise pairings. Note the high-density collocation clusters in the text:

  1. "Negligible fiscal impact" \rightarrow Avoids 'small money effect'. 'Negligible' implies that the amount is so small it can be safely ignored in a professional calculation.
  2. "Muted patient uptake" \rightarrow 'Muted' is a sophisticated metaphorical transfer from acoustics to economics, describing a response that is lower than expected.
  3. "Systemic and clinical impediments" \rightarrow 'Impediments' is surgically more precise than 'problems' or 'barriers,' suggesting a structural slowing of a process.

🎓 Scholarly Synthesis: The 'Discrepancy' Framework

The text employs a sophisticated rhetorical strategy of juxtaposition. Instead of saying "One group says X, but another says Y," the author uses the noun discrepancy as an anchor:

"...a discrepancy exists between professional pharmacy reports and federal records..."

This allows the writer to present conflicting data as a single, observable phenomenon (the discrepancy) rather than a simple disagreement. This is the hallmark of C2 writing: the ability to synthesize opposing facts into a singular, analytical observation.

Vocabulary Learning

volatility (n.)
The quality of being unstable or likely to change rapidly and unpredictably.
Example:The recent volatility in the FDA’s leadership caused widespread uncertainty among pharmaceutical firms.
discrepancy (n.)
A lack of agreement or consistency between two or more facts or figures.
Example:There was a discrepancy between the projected and actual utilization of the new Alzheimer’s therapeutics.
speculation (n.)
The act of forming a theory or guess without firm evidence.
Example:Speculation about the potential removal of Commissioner Makary has fueled administrative uncertainty.
logistical (adj.)
Relating to the detailed coordination and organization of complex operations.
Example:The logistical burdens of intravenous administration and extensive imaging hindered market penetration.
marginal (adj.)
Limited in importance, effect, or value; barely noticeable.
Example:The marginal benefits of the agents were outweighed by the risk of severe adverse events.
hemorrhaging (n.)
The escape of blood from a ruptured blood vessel, often severe or uncontrolled.
Example:Cerebral hemorrhaging is a potential severe adverse event associated with the medication.
deficits (n.)
Shortcomings or lack of something that is required or expected.
Example:The FDA has not formally recognized the deficits in estrogen patch availability.
instability (n.)
The state of being unstable or prone to change or collapse.
Example:Leadership instability at the FDA has disrupted the agency’s regulatory processes.
anticipated (adj.)
Expected or predicted to happen or be achieved.
Example:The high‑cost Alzheimer’s medications failed to meet anticipated adoption rates.
adoption (n.)
The act of taking up, using, or accepting something new.
Example:The adoption of Leqembi and Kisunla has been slower than forecasted.
cohort (n.)
A group of people with a shared characteristic, often studied over time.
Example:The eligible patient cohort for the new therapy remained restricted.
fiscal (adj.)
Relating to government revenue and expenditure, especially in relation to the budget.
Example:The negligible fiscal impact of the drug was noted in the 2026 projections.